Export
Model List of Essential Medicines
clear
Found 18 recommendations for 12 medicines and 13 therapeutic equivalents
Removed recommendations and rejected applications are shown. Hide them.
-
Beinaglutide General information
SectionHypoglycaemic agentsIndicationsTherapeutic equivalent to semaglutide for Obesity -
Canagliflozin General information
SectionOral hypoglycaemic agentsIndicationsTherapeutic equivalent to empagliflozin for Type 2 diabetes mellitus -
Dapagliflozin General information
SectionOral hypoglycaemic agentsIndicationsTherapeutic equivalent to empagliflozin for Type 2 diabetes mellitus -
Dulaglutide General information
SectionHypoglycaemic agentsIndicationsTherapeutic equivalent to semaglutide for Obesity Therapeutic equivalent to semaglutide for Type 2 diabetes mellitus -
Empagliflozin General information
SectionOral hypoglycaemic agents- Oral > Solid: 10 mg; 25 mg
Indications -
Exenatide General information
SectionHypoglycaemic agentsIndicationsTherapeutic equivalent to semaglutide for Obesity -
Glibenclamide General information
SectionOral hypoglycaemic agents- Oral > Solid: 5 mg; 2.5 mg
Indications -
Gliclazide General information
SectionOral hypoglycaemic agents- Oral > Solid: 30 mg controlled-release; 60 mg controlled-release; 80 mg controlled-release
Indications -
Insulin (analogue, long-acting) General information
SectionInsulins- Parenteral > General injections > SC: 100 IU per mL in 3 mL cartridge solution; 100 IU per mL in 3 mL pre-filled pen solution; 100 IU per mL in 10 mL vial solution
Indications -
Insulin (analogue, rapid-acting) General information
SectionInsulins- Parenteral > General injections > SC: 100 IU per 1 mL in 10 mL vial; 100 IU per 1 mL in 3 mL cartridge; 100 IU per 1 mL in 3 mL pre-filled pen
Indications -
Insulin (human, intermediate-acting) General information
SectionInsulins- Parenteral > General injections > SC: 40 IU per mL in 10 mL vial as compound insulin zinc suspension or isophane insulin; 100 IU per mL in 10 mL vial as compound insulin zinc suspension or isophane insulin; 100 IU per mL in 3 mL cartridge as compound insulin zinc suspension or isophane insulin; 100 IU per mL in 3 mL pre-filled pen as compound insulin zinc suspension or isophane insulin
Indications -
Insulin (human, short-acting) General information
SectionInsulins- Parenteral > General injections > SC: 40 IU per mL in 10 mL vial solution; 100 IU per mL in 10 mL vial solution; 100 IU per mL in 3 mL cartridge solution; 100 IU per mL in 3 mL pre-filled pen solution
Indications -
Insulin analogues General information
SectionInsulins- Not specified
Indications -
Insulin aspart General information
SectionInsulins- Parenteral > General injections > SC: 100 IU per mL in 110 mL vial; 100 IU per mL in 3 mL cartridge; 100 IU per mL in 3 mL pre-filled pen
- Parenteral > General injections > SC: 100 IU per mL in 10 mL vial; 100 IU per mL in 3 mL cartridge; 100 IU per mL in 3 mL pre-filled pen
IndicationsTherapeutic equivalent to insulin (analogue, rapid-acting) for Type 1 diabetes mellitus Therapeutic equivalent to insulin (analogue, rapid-acting) for Type 2 diabetes mellitus -
Insulin degludec General information
SectionInsulins- Parenteral > General injections > SC: 100 units per mL
IndicationsTherapeutic equivalent to insulin glargine for Type 1 diabetes mellitus Therapeutic equivalent to insulin (analogue, long-acting) for Type 2 diabetes mellitus Therapeutic equivalent to insulin (analogue, long-acting) for Type 1 diabetes mellitus -
Insulin detemir General information
SectionInsulinsIndicationsTherapeutic equivalent to insulin glargine for Type 1 diabetes mellitus Therapeutic equivalent to insulin (analogue, long-acting) for Type 2 diabetes mellitus Therapeutic equivalent to insulin (analogue, long-acting) for Type 1 diabetes mellitus -
Insulin glargine General information
SectionInsulins- Parenteral > General injections > SC: 100 units per mL
IndicationsType 1 diabetes mellitus Therapeutic equivalent to insulin (analogue, long-acting) for Type 2 diabetes mellitus Therapeutic equivalent to insulin (analogue, long-acting) for Type 1 diabetes mellitus -
Insulin glulisine General information
SectionInsulins- Parenteral > General injections > SC: 100 IU per mL in 10 mL vial; 100 IU per mL in 3 mL cartridge; 100 IU per mL in 3 mL pre-filled pen
IndicationsTherapeutic equivalent to insulin (analogue, rapid-acting) for Type 1 diabetes mellitus Therapeutic equivalent to insulin (analogue, rapid-acting) for Type 2 diabetes mellitus -
Insulin lispro General information
SectionInsulins- Parenteral > General injections > SC: 100 IU per mL in 10 mL vial; 100 IU per mL in 3 mL cartridge; 100 IU per mL in 3 mL pre-filled pen
IndicationsTherapeutic equivalent to insulin (analogue, rapid-acting) for Type 1 diabetes mellitus Therapeutic equivalent to insulin (analogue, rapid-acting) for Type 2 diabetes mellitus -
Liraglutide General information
SectionHypoglycaemic agentsIndicationsTherapeutic equivalent to semaglutide for Obesity Therapeutic equivalent to semaglutide for Type 2 diabetes mellitus -
Metformin General information
SectionOral hypoglycaemic agents- Oral > Solid: 500 mg (hydrochloride)
Indications -
Semaglutide General information
SectionHypoglycaemic agents- Parenteral > General injections > SC: 0.25 mg in pre-filled pen injection solution; 0.5 mg in pre-filled pen injection solution; 1 mg in pre-filled pen injection solution; 2 mg in pre-filled pen injection solution; 4 mg in pre-filled pen injection solution
- Oral > Solid > tablet: 3 mg
- Parenteral > General injections > SC: 0.68 mg per mL; 1.34 mg per mL; 2.68 mg per mL
Indications -
Tirzepatide General information
SectionHypoglycaemic agentsIndicationsTherapeutic equivalent to semaglutide for Obesity Therapeutic equivalent to semaglutide for Type 2 diabetes mellitus -
Tolbutamide General information
SectionOral hypoglycaemic agents- Oral > Solid: 500 mg
Indications